APA (7th ed.) Citation

Denkinger, C. M., Janssen, M., Schäkel, U., Gall, J., Leo, A., Stelmach, P., . . . Müller-Tidow, C. (2023). Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19. Nature Cancer, 4(1), 96-107. https://doi.org/10.1038/s43018-022-00503-w

Chicago Style (17th ed.) Citation

Denkinger, Claudia M., et al. "Anti-SARS-CoV-2 Antibody-containing Plasma Improves Outcome in Patients with Hematologic or Solid Cancer and Severe COVID-19." Nature Cancer 4, no. 1 (2023): 96-107. https://doi.org/10.1038/s43018-022-00503-w.

MLA (9th ed.) Citation

Denkinger, Claudia M., et al. "Anti-SARS-CoV-2 Antibody-containing Plasma Improves Outcome in Patients with Hematologic or Solid Cancer and Severe COVID-19." Nature Cancer, vol. 4, no. 1, 2023, pp. 96-107, https://doi.org/10.1038/s43018-022-00503-w.